Episode

From Data to Decisions: Powering Growth in MedTech

Podcast
Med Tech Gurus
Published
Apr 1, 2026
Duration seconds
2821
Processing state
not_requested
Canonical source
https://med-tech-gurus.libsyn.com/from-data-to-decisions-powering-growth-in-medtech
Audio
https://traffic.libsyn.com/secure/med-tech-gurus/332_From_Data_to_Decisions_-_Powering_Growth_in_MedTech.mp3?dest-id=1513100
JSON
/v1/public/podcasts/med-tech-gurus-783906/episodes/from-data-to-decisions-powering-growth-in-medtech
Markdown
/podcast/med-tech-gurus-783906/from-data-to-decisions-powering-growth-in-medtech.md

Actions

  • POST https://stenobird.com/v1/public/podcasts/med-tech-gurus-783906/episodes/from-data-to-decisions-powering-growth-in-medtech/transcription-requests
    Idempotently request low-priority transcript generation for this episode.
  • GET https://stenobird.com/podcast/med-tech-gurus-783906/from-data-to-decisions-powering-growth-in-medtech.md
    Read the agent-friendly Markdown representation of this episode resource.

Summary

What if getting breakthrough devices to the right patients wasn't a guessing game — but a data-driven science? In this episode of Med Tech Gurus , we sit down with Mike Monovoukas, CEO and Co-Founder of AcuityMD, one of the fastest-growing platforms in MedTech. Mike shares how his team is turning mountains of messy healthcare data into clear, actionable insights — helping innovators pinpoint the right physicians, facilities, and patient populations, and transforming how devices reach the people who need them most. We explore how AcuityMD is powering precision targeting through AI, why democratizing market intelligence helps level the playing field for new entrants, and how smarter commercialization can unlock access for underserved communities — including their work helping EPI bring the Alpha-Stim device to veterans struggling with pain, insomnia, and anxiety. From designing platforms built specifically for MedTech, to making complex data simple for frontline sales teams, to reshaping how companies scale, Mike delivers a masterclass in building for the future of commercialization — where evidence, empathy, and AI come together.